Haojie
Haojie Li, Lishui CN
Patent application number | Description | Published |
---|---|---|
20140304942 | CONCEALED DOOR CLOSER - A concealed door closer includes a housing, an input shaft and an output shaft, the input shaft being connected to a motor, wherein a joining member is arranged between the input shaft and the output shaft, and two ends of the joining member are respectively provided with an upper connection piece and a lower connection piece, which are connected to a roller via vertical rotation shaft, and wherein both the input shaft and the output shaft are provided with a left connection piece and a right connection piece, which are horizontally connected to the roller via a horizontal rotation shaft. The components in the door closer have a simple structure and may be easily processed and assembled. The size of the joint after assembly is equivalent to that of the joining member, so the overall size is small. | 10-16-2014 |
Haojie Zhang, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20140129917 | VALUE-ADDED USAGE OF PROCESS-ORIENTED EXTENSION FIELDS IN BUSINESS MASHUPS - A method for value-added usage of process-oriented extension fields in business mashups may include generating, using at least one processor, a mashup component with m unbound parameter; receiving input identifying the creation of an extension field, the extension field tied to data stored in a database; binding the unbound parameter of the mashup component to the extension field: presenting an application interlace, the application interface including the extension field; receiving a request to load tee mashup component; and in response to receiving the request passing the data tied to the extension field as an input parameter to the mashup component. | 05-08-2014 |
Haojie Zhou, Jinan CN
Patent application number | Description | Published |
---|---|---|
20130158030 | PYRROLYL SUBSTITUTED DIHYDROINDOL-2-ONE DERIVATIVES, PREPARATION METHODS AND USES THEREOF - Provided are pyrrolyl substituted dihydroindol-2-one derivatives represented by formula (I), pharmaceutically acceptable salts or solvates of said derivatives, or solvates of said salts, which are effective tyrosine kinase inhibitors. Also provided are the preparation methods of the above compounds, pharmaceutical compositions containing these compounds, and the use of these compounds in manufacturing drugs useful for the treatment or adjunctive treatment of tumors medicated by tyrosine kinases or proliferation or migration of tumor cells driven by tyrosine kinases in mammals (including human). | 06-20-2013 |